Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: Results from three randomized placebo-controlled phase III trials: Part I

David M. Pariser*, Kenneth B Gordon, Kim A. Papp, Craig L. Leonardi, Paul Kwon, Peter G. Compton, Amy Chen Rundle, Patricia A. Walicke, Mark Lebwohl

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: Results from three randomized placebo-controlled phase III trials: Part I'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS